Augmedix (NASDAQ:AUGX) PT Lowered to $5.00

Augmedix (NASDAQ:AUGXGet Free Report) had its target price cut by equities researchers at Maxim Group from $6.50 to $5.00 in a research report issued on Tuesday, Benzinga reports. The firm currently has a “buy” rating on the stock. Maxim Group’s price target points to a potential upside of 24.07% from the stock’s current price.

Separately, Evercore ISI assumed coverage on shares of Augmedix in a report on Friday, December 15th. They set an “inline” rating and a $6.00 price target for the company.

Get Our Latest Stock Analysis on Augmedix

Augmedix Price Performance

AUGX opened at $4.03 on Tuesday. The company has a fifty day simple moving average of $4.39 and a 200 day simple moving average of $4.94. The firm has a market cap of $166.68 million, a price-to-earnings ratio of -8.96 and a beta of -0.14. Augmedix has a twelve month low of $1.34 and a twelve month high of $6.25. The company has a current ratio of 1.34, a quick ratio of 1.34 and a debt-to-equity ratio of 17.18.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of AUGX. Acadian Asset Management LLC bought a new position in shares of Augmedix during the 3rd quarter valued at about $48,000. Symmetry Peak Management LLC purchased a new stake in shares of Augmedix in the 4th quarter valued at approximately $88,000. Vontobel Holding Ltd. raised its stake in Augmedix by 9.0% during the 4th quarter. Vontobel Holding Ltd. now owns 188,815 shares of the company’s stock valued at $1,105,000 after purchasing an additional 15,606 shares during the period. Worth Venture Partners LLC purchased a new stake in shares of Augmedix in the third quarter valued at $83,000. Finally, Northern Trust Corp boosted its position in shares of Augmedix by 42.7% in the third quarter. Northern Trust Corp now owns 64,144 shares of the company’s stock worth $330,000 after buying an additional 19,205 shares during the period. 71.58% of the stock is currently owned by institutional investors.

Augmedix Company Profile

(Get Free Report)

Augmedix, Inc provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Notes that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, a self-service mobile software application.

See Also

Receive News & Ratings for Augmedix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Augmedix and related companies with MarketBeat.com's FREE daily email newsletter.